Follow The Filings

TSHA position history

The shares of Taysha Gene Therapies (TSHA) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM SHS

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 2,250,000 shares, $15M, 0.07% of portfolio, New
  2. 2026 Q3: 2,249,000 shares, $11M, 0.05% of portfolio, Reduce 0.0%
Holdings date Value % of holdings Shares Filing date All 13F holders